A Phase 1 interventional study of CPTX2309 in healthy adults
Recruiting Phase 1 NCT06917742
Study Description
A study to evaluate the safety and tolerability of an investigational drug called CPTX2309 in healthy adults
Study Details
- Registry ID:
- NCT06917742
- Conditions:
- Healthy Volunteers, Rheumatoid Arthritis, Systemic Lupus Erythematosus
- Phase:
- Phase 1
- Target Enrollment:
- 64 participants
- Start Date:
- Age Range:
- 18–65 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Linear Clinical Research
Nedlands, Western Australia, Australia -
Veritus Research
Bayswater, Victoria, Australia
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.